Addex Therapeutics Ltd header image

Addex Therapeutics Ltd

ADXN

Equity

ISIN CH0029850754 / Valor 2985075

SIX Swiss Exchange (2026-04-30)
CHF 0.05-0.40%

Addex Therapeutics Ltd
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company based in Geneva that develops small‑molecule allosteric modulators, primarily targeting G protein‑coupled receptors and other central nervous system targets, with the aim of producing more selective therapies for neurological and neuropsychiatric disorders. Its pipeline has emphasized mGlu5 negative allosteric modulation for levodopa‑induced dyskinesia in Parkinson’s disease and related CNS indications, and the company combines proprietary discovery capabilities with external collaborations to advance candidates through preclinical and clinical development.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-17.1%1Y
-60.3%3Y
-96.8%5Y

Performance

67.0%1Y
96.5%3Y
95.8%5Y

Volatility

Market cap

7 M

Market cap (USD)

Daily traded volume (Shares)

302,462

Daily traded volume (Shares)

1 day high/low

0.058 / 0.0528

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
2.00
Innovation:
starstarstarstarstar
5.00
Society:
starstarstarstarstar
5.00
Nature:
starstarstarstarstar
3.00
Daniela Gie
Germany, 19 Jun 2024
star star star star star
Hedge found is betting on that stock. (Steven Boyd's Armistice Capital ).

EQUITIES OF THE SAME SECTOR

Embla Medical hf
Embla Medical hf Embla Medical hf Valor: 1060135
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.71%DKK 26.75
Basilea Pharmaceutica Ltd, Allschwil
Basilea Pharmaceutica Ltd, Allschwil Basilea Pharmaceutica Ltd, Allschwil Valor: 1143244
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.06%CHF 54.90
H. Lundbeck A/S
H. Lundbeck A/S H. Lundbeck A/S Valor: 119252584
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.13%DKK 35.00
Teladoc Health Inc
Teladoc Health Inc Teladoc Health Inc Valor: 28438140
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.60%USD 6.46
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co Bristol-Myers Squibb Co Valor: 914188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.91%USD 58.22
DocMorris Ltd
DocMorris Ltd DocMorris Ltd Valor: 4261528
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.11%CHF 7.15
Demant A/S
Demant A/S Demant A/S Valor: 32651962
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.47%DKK 209.00
Ensign Group Inc
Ensign Group Inc Ensign Group Inc Valor: 3109721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.59%USD 183.72
Estee Lauder Companies Inc
Estee Lauder Companies Inc Estee Lauder Companies Inc Valor: 99350
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.38%USD 79.30
Alk-Abello A/S
Alk-Abello A/S Alk-Abello A/S Valor: 117689788
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.51%DKK 242.00